BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32702537)

  • 1. Impact of enzyme-inducing anti-epilepsy drugs on lipid levels in elderly patients with epilepsy.
    Okada S; Nishina M; Koizumi K; Katayama M; Inoue S; Suga S
    Epilepsy Res; 2020 Oct; 166():106428. PubMed ID: 32702537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
    Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
    Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antiepileptic drugs on serum lipid levels in adult epilepsy patients.
    Yamamoto Y; Terada K; Takahashi Y; Imai K; Kagawa Y; Inoue Y
    Epilepsy Res; 2016 Nov; 127():101-106. PubMed ID: 27589412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy.
    Eirís JM; Lojo S; Del Río MC; Novo I; Bravo M; Pavón P; Castro-Gago M
    Neurology; 1995 Jun; 45(6):1155-7. PubMed ID: 7783881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
    Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
    Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommended reference values for serum lipids during early and middle pregnancy: a retrospective study from China.
    Wang C; Kong L; Yang Y; Wei Y; Zhu W; Su R; Lin L; Yang H
    Lipids Health Dis; 2018 Oct; 17(1):246. PubMed ID: 30382875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid profiles in patients with acute myocardial infarction in Hakka population in southern China.
    Zhong Z; Liu J; Li B; Li C; Liu Z; Yang M; Zhang Q; Zhong W; Zhao P
    Lipids Health Dis; 2017 Dec; 16(1):246. PubMed ID: 29246160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy.
    Pulitano P; Franco V; Mecarelli O; Brienza M; Davassi C; Russo E
    Seizure; 2017 Dec; 53():1-3. PubMed ID: 29078086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy.
    Mintzer S; Constantino T; Gidal B; Bhargava P; Grinnell T; Blum D
    Epilepsy Res; 2019 Dec; 158():106216. PubMed ID: 31675622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
    Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
    BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Cholesterol Levels within the High Normal Range Are Associated with Better Cognitive Performance among Chinese Elderly.
    Lv YB; Yin ZX; Chei CL; Brasher MS; Zhang J; Kraus VB; Qian F; Shi XM; Matchar DB; Zeng Y
    J Nutr Health Aging; 2016 Mar; 20(3):280-7. PubMed ID: 26892577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antiepileptic drugs and lipid-lowering agents in the United States.
    Mintzer S; Maio V; Foley K
    Epilepsy Behav; 2014 May; 34():105-8. PubMed ID: 24735835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Profile and Changes of Serum Lipid Levels in Epileptic Patients after Cerebral Infarction.
    Ikeda K; Sawada M; Morioka H; Kyuzen M; Ebina J; Nagasawa J; Yanagihashi M; Miura K; Ishikawa Y; Hirayama T; Takazawa T; Kano O; Kawabe K; Iwasaki Y
    J Stroke Cerebrovasc Dis; 2017 Mar; 26(3):644-649. PubMed ID: 27939141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.
    Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A
    Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.
    Mintzer S; Trinka E; Kraemer G; Chervoneva I; Werhahn KJ
    Epilepsia; 2018 Oct; 59(10):1899-1907. PubMed ID: 30178473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994.
    Ferrara A; Barrett-Connor E; Shan J
    Circulation; 1997 Jul; 96(1):37-43. PubMed ID: 9236414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolism characteristics of blood lipids and the correlation analysis of blood lipids and related factors such as age in the middle-aged and elderly men].
    Wang HJ; Si QJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jan; 28(1):89-93. PubMed ID: 22493905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.